Private Room
Ikena Oncology and Inmagene Biopharmaceuticals Announce Merger to Advance Development of Atopic Dermatitis Treatment
Ikena Oncology, Inmagene Biopharmaceuticals, Merger, Atopic Dermatitis, IMG-007, Monoclonal Antibody, OX40, Biopharmaceuticals, Clinical Stage, Private Placement
Crown Laboratories to Acquire Botox Rival Revance Therapeutics for $924M
Crown Laboratories, Revance Therapeutics, Botox rival, Daxxify, acquisition, private deal, skincare company
NGM Bio Secures $122 Million in Funding After Going Private
NGM Bio, funding, private, Column Group, pipeline, orphan diseases